Industry Report – May 2025

The Industry Report in reply-all shares a selection of recent news featuring UPMC Enterprises, our portfolio companies, and partnerships.

This edition includes stories about clinical developments from SparingVision, Avista Therapeutics, Ring Therapeutics, and Werewolf Therapeutics; Brent Burns featured in a HealthLeaders feature story; and Mary Beth Navarra-Sirio quoted about Spark Pediatrics’ latest work.  

UPMC Enterprises

• UPMC Enterprises, Redesign Health Launch New Startup for Chronic Pain Patients 
• The Innovation Enigma: Can Healthcare Find (and Fund) the Right Path to Transformation?

Abridge

• TIME100 Health: Shiv Rao 
• Abridge Named to Forbes AI 50 2025

Arkos Health

• Arkos Health Names Eric Tanner as Chief Executive Officer, Ushering in Next Chapter of Growth and Innovation

Astrata

• Capital District Physicians’ Health Plan, Inc. (CDPHP®) 2025 Case Study: Increasing HEDIS Rates with an NLP-Driven Prospective Review Process

Avista Therapeutics

• Avista Therapeutics Presents In Vivo Data for its AAV Capsid in Inherited Retinal Diseases at Association for Research in Vision and Ophthalmology 2025 Annual Meeting 

BlueSphere Bio

• BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer
• Quantum Leap Healthcare Collaborative Welcomes Three Esteemed Leaders to Its Board of Directors

Butterfly Network

• Butterfly iQ3 Ultrasound Featured in HBO Max’s The Pitt Episodes 12 and 13

Carta Healthcare

• Carta Healthcare Secures $18.25 Million in Series B1 Funding to Accelerate AI-Powered Clinical Data Abstraction and Analytics

Cerevance

• Cerevance Presents Positive Results from Phase 1 Study of CVN293 at American Academy of Neurology 2025 Annual Meeting

Clearsense

• Clearsense Earns NCQA’s Validated Data Stream Status for Second Consecutive Year 

Mozart Therapeutics

• Mozart Therapeutics Presents Preclinical Data Showing Restoration of CD8 Treg Functionality in Type 1 Diabetes and Early Data from their Targeted IL-15 Program at Immunology 2025™ 

Ring Therapeutics

• Ring Therapeutics Presents New Data on its AnelloBricks® Manufacturing Platform at the 28th Annual American Society of Gene & Cell Therapy Conference

Spark Pediatrics

• Reimagining Care for Medically Complex Children

SparingVision

• SparingVision Presents PRODYGY data and Research Update in Two Oral Presentations at ASGCT 2025 
• SparingVision Receives FDA Support to Initiate Phase II trial of SPVN06 in Geographic Atrophy Secondary to Dry-AMD 

Werewolf Therapeutics

• Werewolf Therapeutics Presents New Preclinical Data Further Characterizing its IL-10 INDUKINE Molecule, WTX-921, for the Treatment of Inflammatory Bowel Disease (IBD) at AAI Annual Meeting